Neu­rol­o­gy start­up from Or­biMed col­lab nabs $65M in Se­ries A

Brenig Ther­a­peu­tics closed a $65 mil­lion Se­ries A on Tues­day morn­ing, get­ting back­ing from big-name in­vestors such as New En­ter­prise As­so­ciates and Or­biMed.

The com­pa­ny …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER